Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy.
Saved in:
| Title: | Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy. |
|---|---|
| Authors: | Hearon BF; Department of Orthopaedics, University of Kansas School of Medicine, Wichita, Kansas, USA., Redelman KN; Kansas Imaging Consultants, Wichita, Kansas, USA., Elhomsy GC; Endocrine Division, Department of Internal Medicine, University of Kansas School of Medicine, Wichita, Kansas, USA., Moore DF Jr; Cancer Center of Kansas, Wichita, Kansas, USA.; Department of Internal Medicine, University of Kansas School of Medicine, Wichita, Kansas, USA. |
| Source: | Case reports in oncology [Case Rep Oncol] 2020 Dec 14; Vol. 13 (3), pp. 1483-1489. Date of Electronic Publication: 2020 Dec 14 (Print Publication: 2020). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 101517601 Publication Model: eCollection Cited Medium: Print ISSN: 1662-6575 (Print) Linking ISSN: 16626575 NLM ISO Abbreviation: Case Rep Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
